Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06831929 · ClinicalTrials.gov registry record · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
A NA study of HPV Vaccine, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 2,232
- Enrollment target
- 1
- Study location
NCT06831929: Recruiting NA study of HPV Vaccine, sponsored by University of California, Davis.
NCT06831929 is a NA study of HPV Vaccine that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 2,232 participants, below the 25,949-participant average among 3 other HPV Vaccine trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06831929, a NA study of HPV Vaccine, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,232 participants
- Enrollment target
- 1
- Study location
Study Summary
Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.
Primary Outcome
Number of participants who initiate and complete the HPV vaccine series
Conditions Studied
Interventions
- BEHAVIORAL Intervention Arm
Study Locations (1)
California
- University of California Davis Health - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,232 participants |
| Start Date | 2025-02-28 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06831929 shows while recruiting
NCT06831929 is an interventional study that assigns participants to a tested intervention. Its 2,232 participants enrollment target places it among the larger protocols in the corpus, below the 25,949-participant average among 3 other HPV Vaccine trials with a reported enrollment target (91% lower).
The record links to 1 condition, with HPV Vaccine appearing as the primary indexed condition, and to 1 intervention - of which Intervention Arm is the first listed.
NCT06831929 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06831929 about?
NCT06831929 is a clinical study titled "HPV Ends Here: Increasing Uptake of the HPV Vaccine". Develop, implement, and evaluate a culturally tailored multilevel intervention to increase uptake of the HPV vaccine among eligible patients ages 10-12 of the University of California, Davis Health Community Physician (UCDH CP) primary care practices using a randomized controlled trial design.
What is the current status of trial NCT06831929?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,232 participants. The study started on 2025-02-28. Estimated completion is 2026-12-31.
What conditions does trial NCT06831929 study?
This clinical trial studies the following conditions: HPV Vaccine.
What interventions are being tested in trial NCT06831929?
The interventions under investigation include: Intervention Arm (BEHAVIORAL).
Who is sponsoring clinical trial NCT06831929?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06831929 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HPV Vaccine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI